Brief: Paradigm Biopharmaceuticals Receives Regulatory & Ethics Approvals For Para_OA_002 Clinical Trial
13/03/2023 22:00
March 14 (Reuters) - Paradigm Biopharmaceuticals Ltd
PAR.AX :
* RECEIVED REGULATORY AND ETHICS APPROVALS FOR PARA_OA_002
CLINICAL TRIAL IN BELGIUM, POLAND, CZECH REPUBLIC
Source text for Eikon: ID:nASX9jSQGw
Further company coverage: PAR.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Paradigm Biopharmaceuticals
See all newsBrief: Paradigm Biopharmaceuticals Says Board Initiates Voluntary Administration
Brief: Paradigm Biopharmaceuticals Seeks Trading Halt
Australia's Paradigm Biopharmaceuticals slips on discounted placement
Brief: Paradigm Biopharmaceuticals Says Co Completes A$14 Mln Placement
Brief: Paradigm Biopharmaceuticals Requests Trading Halt